Filing Details
Phio Pharmaceuticals Corp. (NASDAQ:PHIO) filed a Form 8-K with the Securities and Exchange Commission on July 21, 2026, disclosing a material event.
8k filedNASDAQ:PHIO
Phio Pharmaceuticals Corp. (PHIO) Reports Material Event to SEC
Filing Details Phio Pharmaceuticals Corp. (NASDAQ:PHIO) filed a Form 8-K with the Securities and Exchange Commission on July 21, 2026, disclosing a material event. Market Context…
Market Context
Phio Pharmaceuticals Corp.'s stock currently trades at $1.13 with a market capitalization of $12.4M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Phio Pharmaceuticals Corp.'s stock.
All SEC filings for Phio Pharmaceuticals Corp. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View PHIO Stock Page
Frequently Asked Questions
Where can I read PHIO's SEC filings?
Browse all filings on our PHIO SEC filings page.
What types of SEC filings does Phio Pharmaceuticals Corp. file?
Public companies like Phio Pharmaceuticals Corp. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.